Follicular keratosis (Darier-White), including avohilmo

Q17_FOLLICULAR_KERATOSIS_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — Q82.81 Hospital discharge: ICD-10 — Q82.81 Hospital discharge: ICD-9 — 7573K Cause of death: ICD-10 — Q82.81 Cause of death: ICD-9 — 7573K 3 out of 7 registries used, show all original rules.	55
4. Check minimum number of events None	55
5. Include endpoints None	55
6. Filter based on genotype QC (FinnGen only)	50

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF13

NAME	Q17_FOLLICULAR_KERATOSIS_WIDE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	Q8281
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Q8281
HD_ICD_9	7573K
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Q8281
COD_ICD_9	7573K
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Follicular keratosis (Darier-White), including avohilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Follicular keratosis (Darier-White)

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	50	33	17
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	50.51	48.37	54.65

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
53: Matched controls
530

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Q82.81

ICD-10 Finland

Keratosis follicularis [Darier-White]

+∞

70.7

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

43.5

44.2

D05BB02

ATC

acitretin; oral

52.0

18.9

Q82.88

ICD-10 Finland

Other specified congenital malformations of skin

+∞

16.5

E0000UV, ,

ATC

10.6

13.3

153

Q82.80

ICD-10 Finland

Benign familial pemphigus [Hailey-Hailey]

+∞

13.0

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

19.2

13.0

D07BA04

ATC

hydrocortisone and antiseptics; topical

13.1

11.5

D02AE01

ATC

carbamide; topical

14.1

9.9

E000001, ,

ATC

5.5

8.6

D07AC01

ATC

betamethasone; topical

5.2

8.1

121

S29

ICPC

Skin symptom/complaint other

5.1

7.6

L30.9

ICD-10 Finland

Dermatitis, unspecified

4.9

7.2

D10BA01

ATC

isotretinoin; oral

11.5

6.7

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768443) Skin Pathology biopsy report

7.82

5.83

1.5

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

4.34

5.29

3.5

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

115

2.77

3.13

1.4

1.3

20.14

23.64

iu/ml

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3.38

2.61

1.2

41.00

151.34

u/ml

—

(3021589) Normoblasts [#/volume] in Blood

214

2.44

2.47

13.7

10.5

0.00

e9/l

0.50

173

(3013115) Eosinophils [#/volume] in Blood

266

2.51

2.35

9.9

7.0

0.21

0.19

e9/l

0.31

238

(3001604) Monocytes [#/volume] in Blood

258

2.44

2.28

10.1

6.7

0.55

0.59

e9/l

0.41

227

(3006315) Basophils [#/volume] in Blood

258

2.44

2.28

10.0

6.8

0.04

e9/l

0.19

226

(3019198) Lymphocytes [#/volume] in Blood

259

2.42

2.24

10.3

6.8

1.79

1.84

e9/l

0.18

232

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

3.87

2.14

1.1

1.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

3.68

2.04

1.3

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

4.48

1.86

1.2

1.3

—

(3018010) Neutrophils/Leukocytes in Blood

233

2.10

1.79

10.6

7.0

59.29

56.91

0.63

221

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

4.13

1.75

1.8

1.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

287

2.14

1.68

11.7

10.7

4.47

4.01

e9/l

0.56

256

(3026493) Urate [Moles/volume] in Serum or Plasma

128

2.06

1.67

2.0

2.7

347.48

338.56

umol/l

0.15

115

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

3.56

1.56

2.2

1.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3.56

1.56

2.2

1.5

—

(3000850) Epithelial cells [#/volume] in Urine

107

2.03

1.51

3.3

2.4

7.79

8.58

e6/l

0.08

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

3.34

1.47

1.6

—

(40761535) Cells panel - Urine sediment

2.79

1.24

3.0

4.4

—

(3018418) pH of Serum or Plasma

132

1.83

1.21

3.5

4.1

7.40

0.20

(40768804) Tissue Pathology biopsy report

197

1.76

1.16

2.5

1.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.36

1.13

3.0

10.8

23.34

25.12

mmol/l

—

(3026008) Bacteria identified in Urine by Culture

118

1.80

1.10

4.2

2.9

—

(3030467) Casts [#/volume] in Urine by Automated count

127

1.77

1.09

4.3

3.0

0.21

0.35

e6/l

0.51

(3008898) HLA-B27 [Presence]

2.40

1.05

1.2

1.0

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.05

1.05

3.8

1.7

—

(3000494) Fungus identified in Specimen by Culture

1.98

1.03

3.4

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

156

1.70

1.02

3.7

3.0

7.77

21.50

e6/l

0.99

113

(3021440) Promyelocytes/Leukocytes in Blood

2.08

1.01

7.1

5.1

—

0.17

—

(3022313) Gas panel - Capillary blood

0.00

1.01

0.0

3.9

—

(3018095) Leukocytes [#/volume] in Urine

177

1.65

0.95

4.4

3.8

53.20

11.43

e6/l

0.40

118

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

160

1.64

0.91

4.4

2.9

—

(3021601) Nitrite [Presence] in Urine by Test strip

256

1.63

0.90

4.8

3.5

0.00

estimate

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

107

1.71

0.90

1.5

1.3

2.27

8.06

u/ml

—

(42870588) Differential panel, method unspecified - Blood

170

1.62

0.89

7.8

6.5

—

(3026782) Osmolality of Urine

1.78

0.88

3.6

2.3

460.22

532.59

mosm/kgh2o

—

(3035350) Ketones [Presence] in Urine by Test strip

257

1.62

0.88

4.8

3.6

0.00

estimate

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.82

0.85

1.8

1.6

—

(3031040) Bacteria [#/volume] in Urine by Automated count

310

1.64

0.84

5.4

4.3

—

40.73

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

191

1.58

0.83

5.0

3.3

0.00

0.03

estimate

—

(3013512) EKG study

154

1.60

0.83

2.4

3.2

—

(3009261) Glucose [Presence] in Urine by Test strip

260

1.58

0.81

4.8

3.6

0.00

estimate

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.80

0.80

1.9

1.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

174

1.57

0.79

1.9

2.1

109.35

97.55

pmol/l

—

(40758558) Short blood count panel - Blood

147

1.58

0.77

6.0

7.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1.97

0.77

2.7

8.8

1.11

1.16

mmol/l

—

(3025159) Blasts/Leukocytes in Blood

1.91

0.76

7.4

5.5

—

0.15

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.70

0.76

4.2

1.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

103

1.64

0.75

1.7

2.0

—

(3017181) Myelocytes/Leukocytes in Blood

1.86

0.75

7.1

4.8

—

0.69

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.10

0.75

1.6

—

(36304419) Bacteria [Presence] in Urine

130

1.58

0.74

4.2

2.9

—

estimate

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2.02

0.72

3.4

11.5

0.56

0.70

—

(3002179) Metamyelocytes/Leukocytes in Blood

1.77

0.72

5.7

4.3

—

0.47

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1.94

0.70

3.4

11.2

1.02

1.77

—

(3015736) pH of Urine

207

1.50

0.69

3.4

3.2

5.82

6.17

0.96

112

(3041096) Erythrocytes [Presence] in Urine by Automated

151

1.52

0.68

5.0

3.1

0.00

estimate

—

(40760892) CBC W Ordered Manual Differential panel - Blood

115

1.56

0.67

8.8

4.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

0.00

0.62

0.0

2.2

—

(3034770) Mitochondria Ab [Titer] in Serum

0.00

0.61

0.0

1.2

—

(3017732) Neutrophils [#/volume] in Blood

1.66

0.60

3.2

2.5

5.95

7.74

e9/l

—

(40761536) Microorganisms panel - Urine sediment

1.75

0.59

6.8

3.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.70

0.58

1.3

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.52

0.56

1.9

1.8

—

(40768797) Stomach Pathology biopsy report

1.61

0.54

1.2

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

130

1.45

0.53

1.2

0.64

1.81

u/ml

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.53

0.49

2.3

3.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.53

0.49

1.6

1.7

—

(3002256) Pathology report gross observation

1.53

0.45

1.5

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.67

0.44

1.2

1.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

0.42

0.0

1.6

—

6.99

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.42

0.0

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.42

0.0

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

0.00

0.41

0.0

1.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.40

0.0

2.9

—

160.89

—

(3042936) Bacteria identified in Isolate by Culture

1.34

0.39

1.3

1.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.41

0.38

1.4

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

153

0.72

0.37

2.5

2.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

101

1.38

0.36

1.5

1.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

111

1.36

0.34

1.6

1.9

0.63

1.49

mg/l

0.76

(3023368) Bacteria identified in Blood by Culture

122

1.32

0.31

5.3

4.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.39

0.31

3.8

1.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

123

1.31

0.29

1.3

1.4

2.30

2.55

g/l

—

(3029937) Albumin [Presence] in Urine by Test strip

135

1.27

0.25

4.6

3.5

0.00

estimate

—

(3000991) Gas panel - Venous blood

1.24

0.22

3.8

8.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.21

0.22

2.0

6.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1.21

0.22

4.0

8.5

12.10

7.69

mmol/l

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.00

0.21

0.0

2.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

5.9

—

42.15

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.00

0.21

0.0

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(4268621) Lupus anticoagulant assay

0.00

0.21

0.0

1.8

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.21

0.0

3.3

—

55.82

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

0.00

0.21

0.0

3.2

—

3.38

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

36.15

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

0.11

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

(3035933) Granulocytes/Leukocytes in Blood

0.00

0.20

0.0

2.7

—

63.03

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

0.20

0.0

1.3

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.21

0.19

5.1

7.5

105.00

103.68

mmol/l

—

(3000492) Spirometry study

1.15

0.09

1.0

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.05

0.08

1.6

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.06

0.08

1.5

1.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

440

1.15

0.07

6.4

5.4

1.85

1.82

mu/l

0.06

413

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

181

1.08

0.03

3.3

4.0

63.00

18.94

ng/l

0.39

117

(3003694) ABO and Rh group [Type] in Blood

147

0.94

0.02

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

109

1.01

0.00

3.2

4.8

1.05

2.12

ug/l

1.08

102

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

115

1.06

0.00

2.5

2.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

325

1.04

0.00

4.1

3.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.0

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.0

3.4

—

(4195642) Thrombophilia screening test

0.00

0.0

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

0.0

3.3

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.0

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.0

1.4

—

(3011648) Oxygen content in Venous blood

0.00

0.0

3.0

—

10.56

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

0.0

1.1

—

(3035715) Granulocytes [#/volume] in Blood

0.00

0.0

3.4

—

4.96

—

(3003129) Base excess in Capillary blood by calculation

0.00

-0.00

0.0

1.7

—

-1.52

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

-0.00

0.0

1.5

—

1.20

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

138.38

—

(21494815) CD4 cells/Lymphocytes in Specimen

0.00

-0.00

0.0

1.9

—

45.44

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.6

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

1.6

—

110.00

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

-0.00

0.0

1.0

—

(1761868) Lipid panel - Serum or Plasma

220

1.00

-0.00

2.9

3.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

6.7

—

10.02

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

-0.00

0.0

1.5

—

106.67

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

-0.00

0.0

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

0.98

-0.00

3.7

2.3

83.29

91.10

ug/g

—

(3035320) C reactive protein [Mass/volume] in Body fluid

0.00

-0.00

0.0

2.2

—

24.60

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

-0.00

0.0

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

0.86

-0.00

3.4

2.2

36.80

29.91

u/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

-0.00

0.0

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

0.00

-0.00

0.0

2.0

—

0.47

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

-0.00

0.0

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

-0.00

0.0

1.6

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

5.2

—

343.00

—

(3016018) Differential panel - Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.8

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.2

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

-0.00

0.0

1.5

—

4.08

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

220

1.00

-0.00

2.6

2.7

—

estimate

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

-0.00

0.0

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

0.94

-0.00

1.6

1.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

(36660697) Celiac disease serology panel - Serum

0.92

-0.00

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.03

-0.00

1.2

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3022145) Colonoscopy Study observation

1.02

-0.00

2.2

1.4

—

(3023410) Appearance of Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(40768800) Prostate Pathology biopsy report

0.00

-0.00

0.0

1.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.6

—

(3028433) Virus identified in Specimen by Culture

0.00

-0.00

0.0

1.7

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

-0.00

0.0

1.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

287.14

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

74.60

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

-0.00

0.0

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.6

—

(4281824) Cell count and differential, peritoneal fluid

0.00

-0.00

0.0

1.0

—

(40768441) Liver Pathology biopsy report

0.00

-0.00

0.0

1.3

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: Q17_FOLLICULAR_KERATOSIS_WIDE – Follicular keratosis (Darier-White), including avohilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Follicular keratosis (Darier-White), including avohilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Follicular keratosis (Darier-White), including avohilmo (Q17_FOLLICULAR_KERATOSIS_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints